OneTouch® Ping™ Glucose Management System Cleared By FDA

Main Category: Diabetes
Also Included In: Regulatory Affairs / Drug Approvals;  Medical Devices / Diagnostics
Article Date: 04 Jul 2008 - 1:00 PDT

email to a friend   printer friendly   view / write opinions

Animas Corporation announced the clearance of its OneTouch® Ping™ Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.

"OneTouch Ping provides patients the advanced insulin pump technology from Animas plus the OneTouch blood glucose technology they trust, put together into a system that offers the discretion, convenience and option of remote insulin dosing," said Juan Frias, M.D., Chief Medical Officer and Vice President of Medical Affairs, Animas Corporation. "People using OneTouch Ping will no longer have to access their pump to deliver a bolus, ultimately making life with diabetes a little easier."

OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson, Animas makers of insulin pumps and LifeScan makers of the OneTouch brand of glucose meters and OneTouch® Ultra® Test Strips.

OneTouch Ping also offers the following:

-- Lifestyle-focused pump performance - the pump can be clipped to a belt, tucked in a pocket, or secured under clothing, is waterproof up to 12 feet for 24 hours and has a color screen for outstanding pump readability

-- Individualized control - delivers lowest basal increments (0.025 U/hr) and lowest bolus increments (0.05 U) available to more precisely match patient insulin needs

-- Proven blood glucose monitoring technology - the meter-remote utilizes OneTouch Ultra Test Strips, the leading brand of test strips covered by more health plans at the lowest co-pay

ezManager® MAX Diabetes Management Software

The OneTouch Ping system will also work with the recently cleared ezManager® MAX Diabetes Management Software designed to allow users to download important diabetes management data from the insulin pump and meter-remote. Integrated blood glucose data from the meter-remote and insulin dosing data may be downloaded for review, analysis and evaluation of insulin delivery and blood glucose history to better inform healthcare decision-making. The ezManager® MAX software is MAC and PC compatible.

About Animas Corporation

As part of the Johnson & Johnson Family of Companies, Animas is dedicated to creating a world without limits for people with diabetes through a wide range of products, including the Animas 2020 insulin pump, Inset 30 infusion set, ezManager MAX software and the new OneTouch Ping glucose management system. Animas, from the Latin word meaning true inner self or soul, has been committed since 1996 to individual patient needs through the development of life-performance technology and unparalleled customer service live 24 hours a day, 7 days a week, 365 days a year.

To learn more about Animas and its products, visit http://www.animascorp.com.

About LifeScan, Inc.

LifeScan, Inc., a Johnson & Johnson company and the leading maker of blood glucose monitoring products in the U.S., is dedicated to creating a world without limits for people with diabetes. The company develops, manufactures and markets a wide range of glucose monitoring systems and software for use by people with diabetes and health care providers. Every day, more than 4.5 million people with diabetes rely on OneTouch® Brand Products to provide accurate glucose results and help them use this information to take action so they can stay healthy.

For healthcare professional resources, and information on diabetes care and LifeScan products and services, visit http://www.LifeScan.com.

Johnson and Johnson
http://www.jnj.com